Related Targets |
Target- |
Mechanism ATP2C1 blockers [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date18 Sep 1992 |
Target- |
Mechanism ATP2C1 blockers [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date20 Apr 1990 |
Target- |
Mechanism ATP2C1 blockers [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date18 Dec 1979 |
Start Date01 Jan 2025 |
Sponsor / Collaborator University of Zurich [+2] |
Start Date01 Jul 2024 |
Sponsor / Collaborator |
Start Date01 Jul 2024 |
Sponsor / Collaborator |